摘要
目的探讨小牛血清去蛋白注射液治疗脑梗死的临床疗效。方法 68例急性脑梗死患者随机分为两组,试验组34例,对照组34例。对照组给予脑梗死常规治疗;试验组在常规治疗基础上加用小牛血清去蛋白注射液治疗。治疗前后测定血清超敏C反应蛋白(hs-CRP)和美国国立卫生院神经功能缺损评分(NHISS)及临床疗效改善率的差异。结果治疗后,试验组Hs-CRP水平下降明显,与对照组相比,差异具有统计学意义(P <0.05);结合治疗后NIHSS评分,比较治疗组和对照组的总有效率,差异有统计学意义(P <0.05);试验组在治疗过程中未发生不良反应;ADL评分的分级占比情况,试验组与对照组差异具有统计学意义(P <0.05)。结论小牛血清去蛋白注射液可改善患者的神经功能缺损程度,提高临床疗效,安全可靠。
Objective To study the deproteinized calf serum injection on the clinical effect of treatment of cerebral infarction. Methods 68 eases of acute cerebral infarction patients were randomly divided into two groups, the experimental group 34, 34 patients in the control group. Experimental group based on the conventional treatment combined with deproteinized calf serum injection, 10 days.Determin the serum high-sensitivity e-reactive protein （hs-CRP） before and after treatment and the United States national institutes of neurological scores （NHISS） and clinical improvement rate difference.Results After treatment, the treatment group and the control group were compared in total efficiency, the difference was statistically significant （P 〈 0.05）, no adverse reactions occurred during the treatment, and no significant difference was observed between the two groups before and after treatment （P 〉 0.05 ） .Conclusion Deproteinized calf serum injection can improve the patient＇s neurologie impairment and improve clinical outcomes, safe and reliable.
作者
王晓鹏
姚园园
闫妍
王林静
陈蕾
WANG Xiao-peng;YAO Yuan-yuan;YAN Yah(Neurology Department of the Second Hospital of Hebei Medical University,Shijiazhuang 050000,China)
出处
《中国处方药》
2018年第10期92-94,共3页
Journal of China Prescription Drug
关键词
小牛血清去蛋白注射液
脑梗死
NHISS评分
疗效
Deproteinized calf serum injection
Cerebral infaretion
NHISS score
Curative effect
